ELAB
Elevai Labs, Inc. Common Stock
NASDAQ: ELAB · HEALTHCARE · BIOTECHNOLOGY
$2.53
-0.39% today
Updated 2026-04-29
Market cap
$11.08M
P/E ratio
—
P/S ratio
18.78x
EPS (TTM)
$-382.61
Dividend yield
—
52W range
$2 – $269
Volume
9.0M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-2.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -2.43 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.85M
- Revenue declining -45.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $766277.00 | $1.71M | $2.47M | $590084.00 | $590080.00 |
| Net income | $-1.80M | $-4.30M | $-6.25M | $-7.71M | $-2.98M |
| EPS | — | — | — | — | $-382.61 |
| Free cash flow | $-1.62M | $-4.57M | $-5.50M | $-6.38M | $-1.85M |
| Profit margin | -234.94% | -251.17% | -253.14% | -1,306.28% | — |
Peer comparison
Smart narrative
Elevai Labs, Inc. Common Stock trades at $2.53. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -2.43, it sits in the distress. TTM revenue stands at $590080.00.
Frequently asked questions
What is Elevai Labs, Inc. Common Stock's stock price?
Elevai Labs, Inc. Common Stock (ELAB) trades at $2.53.
Is Elevai Labs, Inc. Common Stock overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Elevai Labs, Inc. Common Stock (ELAB)?
The analyst target price is $—, representing NaN% downside from the current price of $2.53.
What is Elevai Labs, Inc. Common Stock's revenue?
TTM revenue is $590080.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-2.43 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio18.78x
ROE-107.30%
Beta0.71
50D MA$5.09
200D MA$87.92
Shares out0.00B
Float0.00B
Short ratio—
Avg volume9.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—